Finasteride
- Product NDC
- 68554-3026
- 11-digit product format
- 685543026
- Labeler code
- 68554
- Product ID
- 68554-3026_302da6ff-cec4-40fc-8635-a8c9c36df508
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Finasteride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Hetero Labs Limited
- Application
- ANDA090060
- Marketing category
- ANDA
- Marketing start
- 2013-07-01
- Marketing end
- 0000-00-00
- Substance
- FINASTERIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68554-3026-0 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |
| 68554-3026-1 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |
| 68554-3026-2 | 2023-08-10 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |
| 68554-3026-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |
| 68554-3026-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |
| 68554-3026-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fc3d-f424-e053-dadaa90a57ce | 302da6ff-cec4-40fc-8635-a8c9c36df508 |